Table 2 Survival stratified by demographic and clinical characteristics
From: Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study
| Covariates | Overall Survival (95% CI) | Disease-specific survival (95% CI) | ||
|---|---|---|---|---|
| 5-year | 10-year | 5-year | 10-year | |
| Entire series | 54% (49–58%) | 40% (35–45%) | 60% (56–65%) | 53% (48–58%) |
| Age (years) | ||||
| < 65 | 60% (54–66%) | 53% (46–59%) | 63% (56–68%) | 55% (48–61%) |
| ≥ 65 | 47% (40–53%) | 26% (19–33%) | 57% (50–64%) | 51% (43–58%) |
| Site | ||||
| Soft tissue of extremity | 57% (51–63%) | 44% (38–50%) | 64% (58–70%) | 57% (50–63%) |
| Soft tissue of axial | 53% (44–61%) | 39% (29–48%) | 58% (49–66%) | 53% (43–62%) |
| Internal tissue/organ | 43% (32–54%) | 27% (16–38%) | 49% (37–61%) | 36% (24–49%) |